Results 271 to 280 of about 50,006 (352)

What matters most: Protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata [PDF]

, 2018
Crayton, Eloise, et al,, Jackson, Sherrill, Margenthaler, Julie, Mir, Nageen, Politi, Mary C   +5 more
core   +1 more source

The impact of young age on outcome after breast-conserving surgery (BCS) and radiation therapy (RT) for Carcinoma in situ of the breast (DCIS)

, 2000
C.C Park, A. Recht, Rebecca Gelman, Stuart J. Schnitt, James L. Connolly, B. Silver, J. R. Harris   +6 more
openalex   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

The Combination of Chest Wall Perforator Flaps and Surgeon-Performed Breast Ultrasound: An Effective Synergy to Expand the Boundaries of Breast-Conserving Surgery. [PDF]

Ann Surg Oncol
Ferrucci M, Milardi F, Passeri D, Miglioranza E, Del Bianco P, Montagna G, Marchet A.   +6 more
europepmc   +1 more source

The role of cytokines in ovarian cancer drug resistance

International Journal of Cancer, Volume 158, Issue 4, Page 821-834, 15 February 2026.
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang, Yunxia Zang, Rebeka Dejenie, Junyuan Bing, Shixia Dong, Yanfei Zhang, Yi Zhu, Jingjing Li   +7 more
wiley   +1 more source

Application of chest wall perforator flaps in oncoplastic breast-conserving surgery. [PDF]

BMC Cancer
Xie L, Kong X, Lin D, Song J, Chen X, Huang P, Gao J.   +6 more
europepmc   +1 more source

Cause‐specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio‐economic status

International Journal of Cancer, Volume 158, Issue 4, Page 873-883, 15 February 2026.
What's new? Ductal carcinoma in situ (DCIS) fails to progress to invasive breast cancer (IBC) in about four‐fifths of women. Nonetheless, once advanced to IBC, risk of death increases. Here, the authors investigated breast cancer mortality in Dutch women with DCIS in light of potential associations with socioeconomic status (SES) and DCIS detection ...
Renée S. J. M. Schmitz, Alexandra W. van den Belt‐Dusebout, Maartje van Seijen, Ellen A. J. Verschuur, Frederieke H. van Duijnhoven, Michael Schaapveld, Esther H. Lips, Jelle Wesseling, Marjanka K. Schmidt   +8 more
wiley   +1 more source

Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2- breast cancer. [PDF]

NPJ Breast Cancer
Han W, Kang E, Jung JG, Kim HK, Lee HB, Kim J, Lee SB, Shin HC, Park CS, Seong MK, Kim HA, Kim EK, Son BH.   +12 more
europepmc   +1 more source

Narrative review of strategies for blood product shelf‐life extension

Transfusion, EarlyView.
Mike Akaraphanth, Jessica Oudakker, Matthew Paulson, Michael Adam Meledeo, Kristin M. Reddoch‐Cardenas, Lusha Xiang, Steven G. Schauer, Todd Getz   +7 more
wiley   +1 more source

Integrated scFv identification and CAR T cell generation for AML targeting in vivo

International Journal of Cancer, Volume 158, Issue 4, Page 994-1007, 15 February 2026.
What's new? Acute myeloid leukemia (AML) is a rapidly progressing blood cancer. Advancing chimeric antigen receptor (CAR) T cell therapies, particularly through rapid translation of single chain variable fragment (scFv) discovery into CAR constructs, may improve clinical outcomes, especially the development of patient individualized CAR T cells.
Yi Liu, Annika Lauk, David Sedloev, Josephine Brysting, Ela Cetin, Chunan Liu, Maximilian Mönnig, Thomas Luft, Haiyang Yun, Michael Schmitt, Tim Sauer, Fengbiao Zhou, Christian Rohde, Carsten Müller‐Tidow   +13 more
wiley   +1 more source